-
Je něco špatně v tomto záznamu ?
MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity
M. Skála, B. Hanousková, L. Skálová, P. Matoušková,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Grantová podpora
814316
Grant Agency of Charles University - International
SVV 260 416
Univerzita Karlova v Praze - International
CZ.02.1.01/0.0/0.0/16_019/0000841
EFSA-CDN-ERDF - International
- MeSH
- biologické markery MeSH
- kardiotoxicita diagnóza genetika MeSH
- lidé MeSH
- mikro RNA genetika MeSH
- nežádoucí účinky léčiv diagnóza genetika MeSH
- srdce účinky léků MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Drug-induced cardiotoxicity is a serious problem associated with the administration of many drugs. MicroRNAs (miRNAs) have been reported to be affected by drugs and other xenobiotics, and the potential of miRNAs as biomarkers and diagnostic tools has been considered. In recent years, an association of certain miRNAs with the cardiotoxicity of some drugs, namely anthracyclines, bevacizumab, cyclosporine A and isoprenaline, has already been found. This review article summarizes available information about the changes in miRNA levels induced by cardiotoxic drugs. Three aspects are discussed: the altered expression of miRNAs in the heart upon treatment with cardiotoxic drugs, circulating miRNAs as promising early biomarkers of cardiotoxicity, and the potential of miRNAs in the prevention and/or attenuation of drug-induced cardiotoxicity. The targeted changes in the level of certain miRNAs by antagomiRs and miRNA mimics are also described and evaluated. In addition, the cardioprotective mechanism of various natural compounds via their effect on miRNA levels are examined.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006723
- 003
- CZ-PrNML
- 005
- 20220606083140.0
- 007
- ta
- 008
- 200511s2019 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00204-018-2356-z $2 doi
- 035 __
- $a (PubMed)30460422
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Skála, Mikuláš $u Faculty of Medicine in Hradec Králové, Charles University, Šimkova 870, Hradec Králové, Czech Republic. Department of Pulmology, University Hospital in Hradec Králové, Sokolská 581, Hradec Králové, Czech Republic. $7 xx0273596
- 245 10
- $a MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity / $c M. Skála, B. Hanousková, L. Skálová, P. Matoušková,
- 520 9_
- $a Drug-induced cardiotoxicity is a serious problem associated with the administration of many drugs. MicroRNAs (miRNAs) have been reported to be affected by drugs and other xenobiotics, and the potential of miRNAs as biomarkers and diagnostic tools has been considered. In recent years, an association of certain miRNAs with the cardiotoxicity of some drugs, namely anthracyclines, bevacizumab, cyclosporine A and isoprenaline, has already been found. This review article summarizes available information about the changes in miRNA levels induced by cardiotoxic drugs. Three aspects are discussed: the altered expression of miRNAs in the heart upon treatment with cardiotoxic drugs, circulating miRNAs as promising early biomarkers of cardiotoxicity, and the potential of miRNAs in the prevention and/or attenuation of drug-induced cardiotoxicity. The targeted changes in the level of certain miRNAs by antagomiRs and miRNA mimics are also described and evaluated. In addition, the cardioprotective mechanism of various natural compounds via their effect on miRNA levels are examined.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a kardiotoxicita $x diagnóza $x genetika $7 D066126
- 650 _2
- $a nežádoucí účinky léčiv $x diagnóza $x genetika $7 D064420
- 650 _2
- $a srdce $x účinky léků $7 D006321
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikro RNA $x genetika $7 D035683
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Hanousková, Barbora $u Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, Hradec Králové, Czech Republic.
- 700 1_
- $a Skálová, Lenka $u Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, Hradec Králové, Czech Republic.
- 700 1_
- $a Matoušková, Petra $u Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, Hradec Králové, Czech Republic. matousp7@faf.cuni.cz.
- 773 0_
- $w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 93, č. 1 (2019), s. 1-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30460422 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20220606083139 $b ABA008
- 999 __
- $a ok $b bmc $g 1525581 $s 1096779
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 93 $c 1 $d 1-9 $e 20181120 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
- GRA __
- $a 814316 $p Grant Agency of Charles University $2 International
- GRA __
- $a SVV 260 416 $p Univerzita Karlova v Praze $2 International
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000841 $p EFSA-CDN-ERDF $2 International
- LZP __
- $a Pubmed-20200511
